Skip to main content
Equibles

Christopher Bowden

Board Member

Bicara Therapeutics Inc. (BCAX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher Bowden

Christopher Bowden is recorded as Board Member at Bicara Therapeutics Inc. (BCAX). Earlier roles on record: Board Member at Alaunos Therapeutics, Inc. (TCRT) until March 30, 2023. Alaunos Therapeutics, Inc. reported in an 8-K filed March 30, 2023 that Christopher Bowden resigned as director, effective March 30, 2023.

“On March 29, 2023, Christopher Bowden, M.D. delivered notice of his resignation from the board of directors (the "Board") of Alaunos Therapeutics, Inc. (the "Company"), effective March 30, 2023.”
Alaunos Therapeutics, Inc. Form 8-K, filed March 30, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Bicara Therapeutics Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.